

For World Asthma Day 2023, the European Respiratory Society (ERS) and the Global Initiative for Asthma (GINA) will join forces to discuss key updates to recommendations about asthma management for adults, adolescents and children in the GINA 2023 strategy report, on the day of its release.
Asthma is a complex disease caused by a mix of genetic and environmental factors which still to this day is the most common chronic disease in children and adolescents globally and one of the most common chronic diseases in adults. Recognized by the World Health Organization (WHO) as both cause and effect of poverty in low- and middle-income countries, it is estimated to affect 339 milion people worldwide.
The webinar will also include discussion about how climate change and air pollution can affect asthma patients, and what clinicians can do to select the most appropriate inhaler for their patients. In light of the new Air Quality Directive proposed by the European Commission, this event will provide an outlook on what is needed to guarantee a healthier future for patients at national, European and global level.
The webinar format will be as follows:
For more information or questions, please email Marta Montanari at ERS.
Helen Reddel is a Research Leader at the Woolcock Institute of Medical Research, Chair of the GINA Science Committee.
Kjeld Hansen is the Chair of the European Lung Foundation (ELF) and has been associated with ELF since 2012. In his professional capacity, Kjeld is working with digitalisation and is employed by the academic institution Kristiania in Oslo, Norway.
In his patient advocacy work, Kjeld is inspired by digitalisation as an enabler for new approaches and organisational forms that put people with respiratory conditions at the centre of the initiative.
None
Company | Purpose of Payment | Amount of funds received* |
---|---|---|
Art Tempi Communications | Compensation of time for contributions to "Patients Today" | A |
None
None
None
None
No. I declare that I have not been full or part time employee of, paid consultant or advisor to /received a grant from the tobacco industry at any time after 1.1.2000, for any project or programme.
A | B | C | D |
---|---|---|---|
less than € 1'000 | € 1001 - € 5'000 | € 5'001 - € 20'000 | more than € 20'000 |